Hello Vet’s latest funding round confirms that European investors now see clinician wellbeing and operational efficiency as core value drivers in veterinary healthcare, not soft add‑ons.
The UK-based veterinary platform has raised EUR 11.81m (GBP 15m) in Series A funding from US growth investor Addition and mission-led fund Future Positive. The round, backed by 15 leading and specialist veterinary professionals as co-investors, lifts total funding to around EUR 24.7m (GBP 21m) following a GBP 6m seed round in August 2023.
This is a mid-market sized bet on a very specific thesis: that solving burnout and admin overload in vet practices is now a hard commercial imperative.
Clinician wellbeing moves to the centre of the thesis
Hello Vet is built around a simple idea: better outcomes for pets and owners start with happier, better-supported veterinary teams. The company explicitly prioritises clinician wellbeing and retention, positioning itself as an antidote to a profession where one in three veterinary professionals is considering leaving within five years.
Its clinical model is designed to change how care is delivered and experienced:
- Team-first operating model: workflows and rotas are structured to support balance and retention, not just throughput.
- Collaborative care: pet owners are invited into treatment and recovery rooms, turning consultations into joint decision-making rather than opaque back-room care.
- Relationship-driven practice: the group operates on the premise that long-term, personal relationships between teams and owners underpin both clinical and commercial outcomes.
For investors, this aligns squarely with the broader healthcare IT and services thesis: platforms that improve outcomes for all stakeholders – clinicians, patients, and payers – command premium valuations and defensible positions.
AI and workflow automation as the enabling layer
Underpinning Hello Vet’s model is proprietary technology and AI designed to strip out routine administrative work. The company says its tools can cut administrative time by up to 90%, freeing clinicians to focus on clinical work and client interaction.
In a sector where practice management software has historically digitised paperwork rather than redesigned workflows, that claim matters. It positions Hello Vet not as another practice roll-up, but as an integrated operator‑tech platform:
- Efficiency as margin: less time on admin translates into more capacity per clinician and better utilisation of existing staff, a critical lever in a talent-constrained market.
- Data as infrastructure: a tech-native platform can standardise data capture and clinical pathways across sites, enabling consistent quality, benchmarking and, over time, new service lines.
This is precisely the kind of operational uplift private capital looks for in mid-market healthcare assets: technology that is embedded in the operating model rather than bolted on.
Sector signal: veterinary care joins mainstream healthtech themes
The round is notable less for its absolute size and more for who is backing it and why.
- Institutional growth capital: Addition’s participation places Hello Vet within a global portfolio of tech-enabled healthcare and services businesses, signalling that veterinary care is now being evaluated with the same metrics and expectations as human healthcare platforms.
- Deep sector endorsement: the presence of 15 specialist veterinary co-investors points to broad recognition that the current model is structurally broken – and that solutions must go beyond incremental workflow tweaks.
For the European mid-market, the deal underscores three trends:
- Veterinary healthcare is now an institutional asset class: after a decade of consolidation-focused buy-and-builds, investors are backing operating models that differentiate through experience, data and workforce strategy, not just scale.
- Workforce crisis is an investable theme: burnout and retention are no longer HR issues; they are core risk factors and value drivers. Platforms that can demonstrably improve retention and satisfaction are moving up investors’ priority lists.
- AI in healthcare must be workflow-native: Hello Vet’s pitch is not generic AI, but targeted automation of specific, high-friction tasks. That aligns with where capital is flowing across European healthtech more broadly.
Early traction, but execution risk remains
Hello Vet reports over 7,500 registered patients, a meaningful early footprint for a still-young platform. The fresh capital gives it room to expand its clinic network, deepen its technology stack and test scalability of its model.
Key risks sit where they do for most operator‑tech hybrids:
- Scaling culture and wellbeing: maintaining a clinician-first culture while adding sites at pace is operationally complex and leadership-intensive.
- Proving the economics: the model must show that higher investment in staff experience and technology translates into sustainably superior unit economics versus traditional practices.
If Hello Vet executes, the Series A will look like an early entry into a new wave of veterinary platforms defined less by consolidation and more by experience, data and workforce resilience. For now, the deal stands as a clear signal: in European animal health, backing the wellbeing of clinicians is becoming a mainstream investment strategy, not a niche experiment.